Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.8M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.13M
-
Shares change
-
+973
-
Total reported value, excl. options
-
$4.83M
-
Value change
-
+$4.2K
-
Put/Call ratio
-
2
-
Number of buys
-
8
-
Number of sells
-
-12
-
Price
-
$4.28
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q4 2023
30 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.13M shares
of 10.8M outstanding shares and own 10.47% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (365K shares), NewEdge Advisors, LLC (166K shares), GEODE CAPITAL MANAGEMENT, LLC (95K shares), CM Management, LLC (80K shares), CARLSON CAPITAL L P (60K shares), COMMONWEALTH EQUITY SERVICES, LLC (58.8K shares), RENAISSANCE TECHNOLOGIES LLC (43.8K shares), Redmond Asset Management, LLC (40.7K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (28.8K shares), and Pathway Financial Advisors LLC (28.5K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.